GO:0001607 neuromedin U receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001607 (neuromedin U receptor activity) is a molecular function defined as combining with neuromedin U (NMU) to initiate a change in cell activity [1,3].
• The two principal receptors are NMUR1 (predominantly expressed on type 2 innate lymphoid cells and other peripheral tissues) and NMUR2 (enriched in the central nervous system) [1,3,5].
• NMU-NMUR1 signaling rapidly activates ILC2s, amplifying allergic lung inflammation and driving type 2 cytokine production [1,3,4].
• NMUR2 has been structurally resolved, revealing the ligand-binding pocket and activation mechanism for this class A GPCR.
• Selective NMUR2 peptide agonists have been developed and characterized, providing pharmacological tools to dissect receptor-specific functions [6,7,8].
• NMU signaling also regulates bone formation by modulating osteoblast differentiation and activity.
Description
Neuromedin U receptor activity (GO:0001607) is a molecular function that mediates cellular responses to the neuropeptide neuromedin U (NMU). According to the Gene Ontology, this activity is defined as combining with neuromedin U to initiate a change in cell activity [1,3]. The receptors responsible, NMUR1 and NMUR2, are class A G protein-coupled receptors (GPCRs) that couple to Gq/11 and other signaling pathways to mobilize intracellular calcium and modulate diverse physiological processes [1,3,5]. This function is critical for neuroimmune communication, particularly in the context of type 2 innate lymphoid cell (ILC2) activation and allergic inflammation [1,3,4]. Researchers study GO:0001607 to understand how neuropeptides bridge the nervous and immune systems, how GPCRs achieve ligand specificity, and how dysregulated signaling contributes to asthma, metabolic disorders, and bone diseases [2,3,4]. The availability of selective agonists and structural data for NMUR2 has accelerated pharmacological interrogation of this pathway [5,6,7,8]. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of neuromedin U receptor activity, its mechanisms, key genes, disease relevance, and experimental strategies including CRISPR-based models.
neuromedin U receptor activity At A Glance
| GO ID | GO:0001607 |
|---|---|
| GO term | neuromedin U receptor activity |
| Ontology | molecular_function |
| Synonym | NMUR activity |
| Definition | Combining with neuromedin U to initiate a change in cell activity. |
| Major function | Mediates cellular responses to neuromedin U, including ILC2 activation and neuroimmune signaling [1,3]. |
| Receptor subtypes | NMUR1 (peripheral, ILC2-enriched) and NMUR2 (CNS-enriched) [1,3,5]. |
| Signaling | Gq/11-coupled GPCR; calcium mobilization and downstream kinase activation [1,3,5]. |
| Disease relevance | Allergic asthma, inflammation, bone metabolism, metabolic disorders [2,3,4]. |
What Is GO:0001607?
Neuromedin U receptor activity (GO:0001607) is the molecular function of a receptor that binds the neuropeptide neuromedin U (NMU) and, upon binding, triggers intracellular signaling events that alter cell behavior [1,3]. This activity is synonymous with NMUR activity and is mediated by the GPCRs NMUR1 and NMUR2, which transduce NMU signals to regulate immune cell activation, smooth muscle contraction, and neuronal excitability [1,3,5].
Why Is neuromedin U receptor activity Important in Cell Biology?
Neuromedin U receptor activity is a key node in neuroimmune crosstalk, directly linking neuronal-derived NMU to rapid activation of type 2 innate lymphoid cells and allergic inflammation [1,3,4]. Its importance extends to bone biology, where NMU signaling regulates osteoblast differentiation and activity. Understanding this molecular function provides mechanistic insight into asthma exacerbations, metabolic regulation, and potential therapeutic targeting of NMUR1/NMUR2 with selective agonists or antagonists [4,6,7,8].
• Drives rapid ILC2 activation and type 2 cytokine production in allergic lung inflammation [1,3].
• Amplifies airway inflammation in mild asthma, suggesting a target for therapeutic intervention.
• Regulates osteoblast differentiation and bone formation, linking neuropeptide signaling to skeletal health.
• Provides a paradigm for neuropeptide-GPCR signaling in immune cells [1,3].
• NMUR2 is a validated target for obesity and metabolic disorders due to its CNS expression [5,6].
• Selective NMUR2 agonists are pharmacological tools for dissecting receptor-specific functions [6,7,8].
• Structural insights into NMUR2 enable rational drug design.
• CRISPR models of NMUR1/NMUR2 can clarify cell-type-specific roles in vivo [1,3].
Mechanism, Genes and Research Methods
Ligand Binding and Receptor Activation
In simple terms: Neuromedin U binds to its receptor like a key in a lock, switching the receptor on.
Neuromedin U (NMU) is a neuropeptide that binds to NMUR1 and NMUR2, class A GPCRs, with high affinity [1,3,5]. Structural studies of NMUR2 reveal that the ligand occupies a canonical orthosteric pocket, triggering conformational changes that activate the receptor. This activation initiates downstream signaling, primarily through Gq/11 proteins, leading to calcium release and cellular responses [1,3].
Downstream Signaling Cascades
In simple terms: Once switched on, the receptor sends signals inside the cell that change its behavior.
Activated NMUR1 and NMUR2 couple to Gq/11, stimulating phospholipase C and increasing intracellular calcium [1,3]. In ILC2s, this leads to rapid production of type 2 cytokines such as IL-5 and IL-13, amplifying allergic inflammation [1,3,4]. The signaling is rapid and potent, as shown by NMU-mediated activation of airway ILC2s in mild asthma.
Receptor Subtypes and Tissue Distribution
In simple terms: Different receptors are found in different parts of the body, giving NMU diverse roles.
NMUR1 is predominantly expressed on peripheral immune cells, especially ILC2s, and mediates neuroimmune activation [1,3]. NMUR2 is highly expressed in the central nervous system and regulates energy homeostasis and pain perception [5,6]. This differential distribution underlies the pleiotropic effects of NMU signaling [1,3,5].
Regulation of Receptor Activity
In simple terms: The receptor's activity can be tuned up or down by other molecules and cellular states.
NMUR2 activity can be modulated by synthetic peptide agonists that are chemically stable and selective, providing tools to study receptor-specific regulation [6,7,8]. Additionally, the receptor's function is influenced by its expression level and the availability of NMU, which is released from neurons and other sources [1,3]. In osteoblasts, NMU signaling regulates differentiation, indicating that receptor activity is integrated with bone remodeling pathways.
Key Genes Involved in GO:0001607 neuromedin U receptor activity
The following genes and proteins are central to neuromedin U receptor activity and its downstream effects.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NMU | Ligand for NMUR1/NMUR2 | Neuropeptide that activates receptors; knockout models show loss of ILC2 activation [1,3]. |
| NMUR1 | Receptor for NMU on ILC2s and peripheral tissues | Mediates neuroimmune crosstalk; KO reduces allergic inflammation [1,3]. |
| NMUR2 | CNS-enriched receptor for NMU | Regulates energy homeostasis; structural studies enable drug design [5,6]. |
| ILC2 markers (e.g., GATA3, RORα) | Transcription factors for ILC2 identity | Required for NMU responsiveness in ILC2s [1,3]. |
| IL5 | Type 2 cytokine | Produced upon NMU-NMUR1 activation; drives eosinophilia [1,3]. |
| IL13 | Type 2 cytokine | Key effector of allergic inflammation downstream of NMUR1 [1,3,4]. |
| GNAQ | Gq alpha subunit | Couples NMUR1/2 to calcium signaling [1,3]. |
| GNA11 | Gq alpha subunit | Alternative Gq protein for NMUR signaling [1,3]. |
| PLCβ | Phospholipase C beta | Generates IP3 and DAG upon receptor activation [1,3]. |
| RUNX2 | Osteoblast transcription factor | NMU signaling modulates osteoblast differentiation. |
| SP7 (Osterix) | Osteoblast transcription factor | Downstream of NMU in bone formation. |
| BGLAP (Osteocalcin) | Bone matrix protein | Marker of osteoblast activity regulated by NMU. |
| CALCA | Neuropeptide related to NMU | Co-expressed in sensory neurons; potential modulator. |
| TRPV1 | Nociceptor ion channel | Co-expressed with NMU in sensory neurons. |
| IL33 | Alarmin activating ILC2s | Synergizes with NMU in ILC2 activation [3,4]. |
| TSLP | Epithelial cytokine | Priming factor for ILC2 responsiveness to NMU. |
| IL25 | Epithelial cytokine | Induces ILC2 activation; interacts with NMU pathway. |
| GATA3 | ILC2 transcription factor | Essential for NMUR1 expression and function [1,3]. |
How Is neuromedin U receptor activity Regulated?
Neuromedin U receptor activity is regulated at multiple levels. Receptor expression is controlled by transcriptional programs in ILC2s, such as GATA3 [1,3]. Ligand availability is governed by neuronal release of NMU, which can be influenced by inflammatory stimuli [1,3]. At the receptor level, synthetic agonists can selectively activate NMUR2, while endogenous regulation may involve desensitization and internalization typical of GPCRs [6,7,8]. In bone, NMU signaling is integrated with osteoblast differentiation pathways, suggesting cross-talk with RUNX2 and SP7.
neuromedin U receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NMUR1 | Allergic asthma | Conditional KO in ILC2s; overexpression in mouse lung [1,3,4]. |
| NMUR2 | Obesity / metabolic disorders | CNS-specific KO; knock-in of humanized receptor [5,6]. |
| NMU | Inflammation and bone loss | NMU KO mice; osteoblast-specific overexpression. |
| IL5 | Eosinophilic asthma | Reporter knock-in for IL5 expression [1,3]. |
| IL13 | Type 2 inflammation | Knock-in of IL13 reporter; KO in ILC2s [1,3]. |
Allergic Asthma and Airway Inflammation
NMU-NMUR1 signaling rapidly activates ILC2s in the lungs, leading to type 2 cytokine production and eosinophilic inflammation [1,3]. In mild asthma, NMU mediates rapid activation of airway ILC2s, exacerbating inflammation. Targeting this pathway could reduce asthma severity.
Bone Metabolism Disorders
NMU regulates osteoblast differentiation and activity, suggesting that dysregulated NMU signaling may contribute to osteoporosis or other bone diseases. Modulating NMUR1 activity in osteoblasts could influence bone formation.
Metabolic and CNS Disorders
NMUR2 is enriched in the brain and regulates energy homeostasis, making it a potential target for obesity and metabolic syndrome [5,6]. Selective NMUR2 agonists have been developed for pharmacological studies [6,7,8].
From neuromedin U receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NMUR1 mediate ILC2 activation in vivo? | NMUR1 knockout mouse [1,3]. |
| What is the role of NMUR2 in energy balance? | NMUR2 point-mutation or knockout mouse [5,6]. |
| Can NMU signaling be tracked in real time? | NMUR1 tagged knock-in with fluorescent reporter [1,3]. |
| Does overexpression of NMUR1 exacerbate asthma? | Lung-specific NMUR1 overexpression mouse [3,4]. |
| How does NMU affect osteoblast differentiation? | Osteoblast-specific NMU knockout or overexpression. |
| What is the effect of selective NMUR2 agonists? | NMUR2 knock-in humanized mouse [6,7,8]. |
How to Study the neuromedin U receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Calcium flux assay | Intracellular calcium release | Receptor activation by NMU or agonists [1,3,5]. |
| ELISA | Cytokine concentrations | IL-5/IL-13 production from ILC2s [1,3,4]. |
| Flow cytometry | Cell surface markers and activation state | ILC2 identification and activation [1,3,4]. |
| Cryo-EM | 3D structure of receptor-ligand complex | Mechanistic insight and drug design. |
| qPCR | mRNA expression of NMUR1/2 | Tissue distribution and regulation [1,3]. |
| Western blot | Protein expression and signaling | Phosphorylation of downstream targets [1,3]. |
| Bone histomorphometry | Bone formation parameters | Osteoblast activity in NMU models. |
| Peptide synthesis | Agonist stability and potency | Development of NMUR2-selective agonists [6,7,8]. |
Calcium Mobilization Assays
Measuring intracellular calcium flux upon NMU stimulation is a standard method to assess NMUR1/2 activity [1,3,5]. This assay can be used with synthetic agonists to determine potency and selectivity [6,7,8].
Cytokine Production Assays
ELISA or Luminex for IL-5 and IL-13 from ILC2 cultures or lung homogenates quantifies downstream effects of NMU receptor activation [1,3,4].
Flow Cytometry for ILC2 Activation
Flow cytometry can identify ILC2s and measure activation markers (e.g., CD25, ICOS) after NMU stimulation [1,3,4].
Structural Biology (Cryo-EM)
Cryo-EM structures of NMUR2 bound to ligand reveal binding modes and activation mechanisms, guiding drug design.
How CRISPR Can Be Used to Study GO:0001607 neuromedin U receptor activity
Knockout
CRISPR knockout of NMUR1 or NMUR2 in cell lines or primary ILC2s can abolish NMU responsiveness, confirming receptor specificity [1,3]. In vivo knockout mice validate roles in allergic inflammation and bone metabolism [2,3].
Point Mutation
Introducing point mutations in the ligand-binding pocket of NMUR2 can dissect residues critical for NMU binding and G protein coupling. Such mutants help validate structural models.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into the NMUR1 locus enables real-time tracking of receptor expression and trafficking in ILC2s [1,3]. Humanized NMUR2 knock-in mice facilitate testing of human-specific agonists [6,7,8].
Overexpression
Overexpression of NMUR1 in cell lines or transgenic mice can amplify NMU signaling, useful for studying downstream pathways and disease exacerbation [3,4]. Overexpression of NMU itself can model chronic neuroimmune activation [1,3].
How EDITGENE Supports neuromedin U receptor activity Research
Researchers studying neuromedin U receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor signaling, immune activation, or disease phenotypes. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell and animal models, enabling rigorous functional validation of NMUR1, NMUR2, NMU, and downstream effectors.
Contact EDITGENE today to design your custom CRISPR model for neuromedin U receptor activity research.
Frequently Asked Questions About neuromedin U receptor activity
What is neuromedin U receptor activity?
Neuromedin U receptor activity (GO:0001607) is the molecular function of binding neuromedin U and initiating a change in cell activity, mediated by NMUR1 and NMUR2 [1,3].
What genes are involved in neuromedin U receptor activity?
The key genes are NMU (ligand), NMUR1 and NMUR2 (receptors), and downstream signaling molecules such as GNAQ, GNA11, and PLCβ [1,3,5].
Which receptors bind neuromedin U?
NMUR1 and NMUR2 are the two known receptors for neuromedin U, both class A GPCRs [1,3,5].
What is the role of NMUR1 in allergic asthma?
NMUR1 on ILC2s mediates rapid activation and type 2 cytokine production, amplifying allergic lung inflammation [1,3,4].
How does NMU signaling affect bone?
NMU regulates osteoblast differentiation and activity, influencing bone formation.
What diseases are associated with neuromedin U receptor activity?
Allergic asthma, metabolic disorders, and bone diseases have been linked to NMU signaling [2,3,4].
What are selective NMUR2 agonists?
These are synthetic peptides that specifically activate NMUR2, used to study its function and as potential therapeutics [6,7,8].
How can I study neuromedin U receptor activity in the lab?
Common methods include calcium flux assays, cytokine ELISAs, flow cytometry, and CRISPR knockout models [1,3,5].
What is the structure of NMUR2?
Cryo-EM structures of NMUR2 bound to ligand have revealed the orthosteric binding pocket and activation mechanism.
Can CRISPR be used to model NMU receptor function?
Yes, CRISPR knockout, knock-in, and point mutation models are powerful tools to dissect NMUR1/2 signaling in vitro and in vivo [1,3,5].
Conclusion
Neuromedin U receptor activity (GO:0001607) is a critical molecular function that bridges neuropeptide signaling and immune regulation. Its receptors, NMUR1 and NMUR2, mediate diverse physiological effects ranging from ILC2-driven allergic inflammation to bone metabolism and energy homeostasis [1,2,3,5]. Continued research using CRISPR models and selective pharmacological tools will further elucidate its therapeutic potential in asthma, metabolic disorders, and beyond [4,6,7,8].
References
- 1. Cardoso V et al.. 2017. Neuronal regulation of type 2 innate lymphoid cells via neuromedin U.. Nature 549(7671):277-281 PMID: 28869974
- 2. Hsiao YT et al.. 2020. Neuromedin U (NMU) regulates osteoblast differentiation and activity.. Biochem Biophys Res Commun 524(4):890-894 PMID: 32057362
- 3. Wallrapp A et al.. 2017. The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation.. Nature 549(7672):351-356 PMID: 28902842
- 4. Ju X et al.. 2024. Neuromedin-U Mediates Rapid Activation of Airway Group 2 Innate Lymphoid Cells in Mild Asthma.. Am J Respir Crit Care Med 210(6):755-765 PMID: 38598774
- 5. Zhao W et al.. 2022. Ligand recognition and activation of neuromedin U receptor 2.. Nat Commun 13(1):7955 PMID: 36575163
- 6. Mehrotra S et al.. 2022. Unanticipated Characteristics of a Selective, Potent Neuromedin-U Receptor 2 Agonist.. ACS Bio Med Chem Au 2(4):370-375 PMID: 37102164
- 7. Takayama K et al.. 2020. A chemically stable peptide agonist to neuromedin U receptor type 2.. Bioorg Med Chem 28(10):115454 PMID: 32247748
- 8. Nishizawa N et al.. 2017. A potent neuromedin U receptor 2-selective alkylated peptide.. Bioorg Med Chem Lett 27(20):4626-4629 PMID: 28935264
